Review
Published on 29 Aug 2024
Unravelling oncosis: morphological and molecular insights into a unique cell death pathway
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450998
- 1,362 views
Type at least 3 characters
6,679 articles
Articles
Systematic Review
Published on 29 Aug 2024
Evaluating the efficacy and safety of different neoadjuvant immunotherapy combinations in locally advanced HNSCC: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1467306
- 1,331 views
Original Research
Published on 29 Aug 2024
Identification of cancer stem cell-related genes through single cells and machine learning for predicting prostate cancer prognosis and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1464698
- 1,026 views
Original Research
Published on 29 Aug 2024
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1457887
- 2,118 views
Review
Published on 29 Aug 2024
The role of B7-H4 in ovarian cancer immunotherapy: current status, challenges, and perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1426050
- 1,531 views
Review
Published on 29 Aug 2024
Neuroendocrine neoplasms of the thymus
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1465775
- 665 views
Original Research
Published on 27 Aug 2024
Single-cell and spatial transcriptome assays reveal heterogeneity in gliomas through stress responses and pathway alterations
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1452172
- 1,758 views
Review
Published on 27 Aug 2024
Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446937
- 1,732 views
Original Research
Published on 27 Aug 2024
Lactylation signature identifies liver fibrosis phenotypes and traces fibrotic progression to hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433393
- 2,713 views
Original Research
Published on 27 Aug 2024
Bevacizumab reduces cerebral radiation necrosis due to stereotactic radiotherapy in non-small cell lung cancer patients with brain metastases: an inverse probability of treatment weighting analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1399613
- 892 views
Original Research
Published on 26 Aug 2024
CircRNAs expression profile and potential roles of circRERE-PMN in pre-metastatic lungs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1455603
- 887 views
Original Research
Published on 26 Aug 2024
A comprehensive landscape analysis of autophagy in cancer development and drug resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1412781
- 1,546 views
Original Research
Published on 26 Aug 2024
Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1439877
- 1,210 views
Original Research
Published on 26 Aug 2024
An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1448485
- 1,191 views
Systematic Review
Published on 26 Aug 2024
Application and prospect of organoid technology in breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1413858
- 2,164 views
Systematic Review
Published on 23 Aug 2024
Efficacy and safety of different regimens of neoadjuvant therapy in patients with hormone receptor-positive, her2-negative breast cancer: a network meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1420214
- 1,658 views